E-therapeutics Plc (ETX.L) LSE

9.00

-0.65(-6.74%)

Updated at May 08, 2024 04:35PM

Currency In GBp

Valuation

Market Cap105.94M
Enterprise Value85.99M
P/E Ratio-4.71
PEG Ratio-0.05
Price/Sales Ratio177.32
Price/Book Ratio2.39
Enterprise/Revenue114.57
Enterprise/EBITDA-2.65

Fiscal Year

Fiscal YearJanuary 31, 2024
Most Recent QuarterJanuary 31, 2024

Profitability

Profit Margin-35.11
Operating Margin-43.38

Management Effectiveness

Return On Assets-0.45
Return On Equity-0.41

Income Statement

Revenue318,000
Revenue/Share0
Gross Profit318,000
EBITDA-13.72M
Net Income-11.17M
Diluted EPS-0.02

Balance Sheet

Total Cash20.67M
Total Cash/Share0.04
Total Debt710,000
Total Debt/Equity0.03
Current Ratio8.87
Book Value Per Share0.04

Price History

52-Week Change-49.15
52-Week High24
52-Week Low9
Moving Average 50 Days11.33
Moving Average 200 Days12.51

Statistics

Average Volume1.04M
Shares Outstanding626.54M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A